Segmental vitiligo: autoimmune pathogenesis, neuronal mechanisms, and somatic mosaicism

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Vitiligo is a depigmentation disorder with nonsegmental (NSV) and segmental (SV) forms.
• Segmental vitiligo (SV) accounts for 5-27.9% of vitiligo cases.
• While NSV is primarily autoimmune, SV's pathogenesis is now also understood as autoimmune.

Purpose of the Study:

• To explore the autoimmune pathogenesis of segmental vitiligo (SV).
• To investigate the role of cytotoxic T cells and mosaicism in SV.
• To reevaluate treatment strategies for SV based on its pathogenesis.

Main Methods:

• Analysis of immune cell populations (CD8+ T cells) in SV lesions.
• Assessment of cytokine levels in active SV.
• Evaluation of lesion distribution patterns and treatment outcomes (autologous melanocyte transplantation).

Main Results:

• Early SV lesions show high levels of melanocyte antigen-specific CD8+ T cells.
• Active SV exhibits increased serum innate immune and CD8+ T cell cytokines.
• Evidence suggests a cytotoxic response targeting mosaic melanocytes in SV, supported by transplantation outcomes.

Conclusions:

• Segmental vitiligo (SV) pathogenesis involves a local cytotoxic response against melanocytes, potentially driven by autoimmune mechanisms.
• Melanocyte mosaicism is a leading theory for SV's segmental distribution and differential treatment response.
• Understanding SV's autoimmune basis supports reevaluating immunosuppressive therapies and highlights the potential of melanocyte transplantation.